A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humans
Crossref DOI link: https://doi.org/10.1007/s00210-015-1134-1
Published Online: 2015-06-26
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Michel, Martin C.
Mayoux, Eric
Vallon, Volker
Text and Data Mining valid from 2015-06-26